An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia

NCT00473434 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone

Sponsor

Janssen-Cilag Pty Ltd